TIM-3
TIM-3 (hepatitis A virus cellular receptor 2, also known as HAVCR2, TIMD3 and CD366) is a cell surface receptor of the immunoglobulin superfamily that modulates innate and adaptive immune responses. It is generally accepted to act as an inhibitory receptor, though its activity depends on cellular context. Browse Assay Genie's current range of TIM-3 research reagents below, or read on for the biology behind the target.
TIM-3 is a cell surface receptor implicated in modulating innate and adaptive immunity. It is generally accepted to have an inhibiting function, although reports of stimulating activity suggest that its effects are shaped by the cellular context and the ligand engaged. It regulates macrophage activation, inhibits T-helper type 1 (Th1)-mediated auto- and alloimmune responses and promotes immunological tolerance. In CD8+ cells it attenuates TCR-induced signalling by blocking NF-kappaB and NFAT promoter activities, resulting in loss of IL-2 secretion. This may involve association with LCK, and/or LGALS9-dependent recruitment of PTPRC to the immunological synapse. In T-cells it has also been shown to activate TCR-induced signalling, probably involving ZAP70, LCP2, LCK and FYN.
TIM-3 is a receptor for galectin-9 (LGALS9) and for phosphatidylserine (PtSer), the latter in a calcium-dependent manner. Galectin-9 binding is believed to suppress T-cell responses, with apoptosis of antigen-specific cells potentially involving TIM-3 phosphorylation and loss of its association with BAG6, although its role as a galectin-9 receptor has been challenged. By recognising PtSer, TIM-3 may mediate phagocytosis of apoptotic cells, and it mediates their engulfment by dendritic cells. On dendritic cells it positively regulates innate responses and, with Toll-like receptors, promotes TNF secretion; in tumour-infiltrating dendritic cells it interacts with HMGB1 to suppress nucleic acid-mediated innate responses. On natural killer cells it can act as a coreceptor enhancing IFN-gamma production, yet it also suppresses NK cell cytotoxicity.
The TIM-3 gene (HAVCR2) encodes a member of the immunoglobulin superfamily and TIM family, and is in the HGNC group of V-set domain containing genes. NCBI describes it as a Th1-specific cell surface protein. It is found at the cell membrane and cell junctions, and has mouse and rat orthologs named Havcr2.
TIM-3 is generally accepted to be an inhibitory receptor that restrains Th1 responses and promotes immunological tolerance.
It attenuates TCR signalling in CD8+ cells by blocking NF-kappaB and NFAT activity, with LCK and PTPRC implicated.
In tumour-infiltrating dendritic cells, TIM-3 interacts with HMGB1 to suppress nucleic acid-mediated innate immune responses.
As a calcium-dependent phosphatidylserine receptor, TIM-3 may recognise apoptotic cells and mediate their engulfment by dendritic cells.
TIM-3 is a cell surface receptor that modulates innate and adaptive immunity, generally with an inhibitory effect. It regulates macrophage activation, inhibits Th1-mediated auto- and alloimmune responses and promotes tolerance. Reports of stimulating activity suggest context or ligand dependence.
TIM-3 is encoded by HAVCR2 and is also known as Tim-3, TIM3, TIMD3, CD366 and FLJ14428. Its full name is hepatitis A virus cellular receptor 2. It belongs to the TIM family of the immunoglobulin superfamily.
TIM-3 is reported as a receptor for galectin-9 (LGALS9) and for phosphatidylserine, the latter binding being calcium-dependent. It also interacts with HMGB1 in tumour-infiltrating dendritic cells. Galectin-9 receptor function has been challenged. Mouse and rat orthologs are both named Havcr2.
Ligands, signalling partners and other immune regulators linked to TIM-3 function, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8TDQ0; product specifications from Assay Genie datasheets.